Package 68462-137-01

{"route": ["ORAL"], "spl_id": "80b48b96-6521-491c-831a-2356c22e39f1", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0368462139011", "0368462137017", "0368462138014"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["1c713b59-a628-42e6-b166-ae71c3913284"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (68462-137-01)", "package_ndc": "68462-137-01", "marketing_start_date": "20071009"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (68462-137-05)", "package_ndc": "68462-137-05", "marketing_start_date": "20071009"}], "brand_name": "Oxcarbazepine", "product_id": "68462-137_80b48b96-6521-491c-831a-2356c22e39f1", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68462-137", "generic_name": "Oxcarbazepine", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "150 mg/1"}], "application_number": "ANDA077802", "marketing_category": "ANDA", "marketing_start_date": "20071009", "listing_expiration_date": "20261231"}